Latest News

Social Security recipients don't want that key information postponed.

Specialty products refiner Calumet (NASDAQ:CLMT) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 40.8% year on year to $...

The space economy is heating up, and with these two space stocks down about 50% from their highs, now could be an excellent time for investors to scoop up shares.

CVS Health raised guidance after a strong Q2, but shares fell nearly 5% after executives flagged expected Caremark membership declines in 2026 and a 340B headwind persisting into 2027.

Your emergency fund target is three to six months of expenses. See how much that is at every income level, plus when to aim low and when to save more.

The S&P 500 just had another flashing sign that could hint at a violent move to come.

Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 25.9% ...

The company's cloud computing business could lead Amazon to new heights.

Household products company Spectrum Brands (NYSE:SPB) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.7% year on year to $753.3 million...

The RMR Group (NASDAQ:RMR) reported fiscal third-quarter 2026 results that met its expectations, with distributable earnings of $0.48 per share and adjusted EBITDA of $19.7 million, as the real estate manager continued to emphasize improving the performance of its managed REITs and expanding its pri

Roivant Sciences (NASDAQ:ROIV) said it expects a busy second half of 2026, with a potential launch of brepocitinib in dermatomyositis, several clinical readouts and additional regulatory discussions across its pipeline. Chief Executive Officer Matt Gline characterized the quarter as relatively quie

RCI Hospitality (NASDAQ:RICK) reported higher third-quarter revenue, earnings and adjusted EBITDA, while management emphasized debt reduction, a turnaround effort at its Bombshells sports-bar business and plans to resume more meaningful stock repurchases after lowering leverage. Interim CFO Albert

B. Riley Financial (NASDAQ:RILY) reported second-quarter net income attributable to common shareholders of $19 million, or $0.45 per diluted share, as its capital markets, wealth management and communications businesses contributed to what Chairman, Founder and Co-CEO Bryant Riley called the company

Relmada Therapeutics (NASDAQ:RLMD) said it is prioritizing manufacturing activities for NDV-01, its sustained-release intravesical formulation of gemcitabine and docetaxel for non-muscle invasive bladder cancer, as it targets an investigational new drug application filing by the end of 2026. Chief

REGENXBIO (NASDAQ:RGNX) reported second-quarter 2026 progress across its late-stage gene-therapy pipeline, highlighting completed enrollment in its Duchenne muscular dystrophy confirmatory study, an agreed path to resubmit its Hunter syndrome therapy application, and the start of a pivotal diabetic

Rigetti Computing (NASDAQ:RGTI) reported second-quarter 2026 revenue of approximately $5.1 million, up from $1.8 million a year earlier, as the quantum computing company recognized revenue from previously announced on-premises Novera quantum processing unit purchase orders. Chief Executive Officer

Carl Zeiss Meditec (ETR:AFX) reported lower revenue and profitability for the first nine months of fiscal 2025/2026, as foreign-exchange effects, weakness in ophthalmology consumables and the suspension of certain bifocal intraocular lens sales in China weighed on results. Order entry totaled €1.60

Deutsche Beteiligungs (ETR:DBAN) reported a busy but “unsatisfying” first half, citing a sharp decline in valuation multiples that outweighed positive operating performance across its portfolio. The private equity investor signed seven transactions during the period, including three acquisitions and

Modular flooring manufacturer Interface (NASDAQ:TILE) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 5.4% year on year ...

Investors look to prediction markets for higher returns, but that's probably a bad idea.

Investors want to forget about the fact that this dominant company's shares have underperformed the S&P 500 index in the last five years.

Mortgage insurance provider Essent Group (NYSE:ESNT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 13.6% year on year to $362.7 million...

Local television broadcasting and media company Gray Television (NYSE:GTN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 8...

Sector ETFs give the impression of diversification. Most of them don't have it.

MoS2 Quantum Dot Photoluminescent Non-Toxic Biocompatible Market was valued at USD 48.7 million in 2025 and is projected to reach USD 142.6 million by 2034